InvestorsHub Logo

raja48185

11/10/20 7:51 PM

#282424 RE: TempePhil #282410

Thank You.

bennyboy1

11/10/20 8:26 PM

#282428 RE: TempePhil #282410

TempePhil: Beautifully done, thanks much. I assume you live in Arizona, I am in Sun City West.

abew4me

11/10/20 9:16 PM

#282434 RE: TempePhil #282410

That's a very user-friendly chart. Thank you for creating it. Very, very impressive.

attilathehunt

11/10/20 10:58 PM

#282458 RE: TempePhil #282410

very nice. Thank you!

tootalljones

11/11/20 12:05 AM

#282464 RE: TempePhil #282410

most everybody on the board benefits and thanks you phil....i know i do

jimmy_mcyoloswag

11/11/20 1:58 AM

#282473 RE: TempePhil #282410

Thanks! This needs to be a sticky.

B60611

11/11/20 2:21 AM

#282475 RE: TempePhil #282410

Great stuff, Thanks!. The only thing I noticed was that Part B of the US Rett trial has 25 patients (15 drug, 10 placebo, whereas it was originally going to be 9 drug, 6 placebo). The 6 person open-label cohort is included in the the 31 figure.

Turner2017

11/11/20 4:36 AM

#282488 RE: TempePhil #282410

Wow! Great DD! love the chart. Thank you very much

mrplmer

11/11/20 7:31 AM

#282502 RE: TempePhil #282410

Thanks for the work.

Turner2017

11/11/20 7:54 AM

#282503 RE: TempePhil #282410

When do you think approval can happen with the US trial? Will fast track let them skip phase 3?